Maladies systémiques et système nerveux central: étude rétrospective de 194 patients en médecine interne
M. Carreiro, P Artet(Hôpital Rangueil), C. Dingremont(Hôpital Rangueil), E Bousquet(Hôpital Rangueil), I. Berry(Centre Hospitalier Universitaire de Toulouse), H. Juchet(Hôpital Rangueil), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), M. Tubéry
Cited by 0
Related Papers
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
|Nature Medicine|2000|515
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.
|Journal of Neurology Neurosurgery & Psychiatry|1991|371
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
|Nature Medicine|2024|109
Acute interstitial nephritis related to immune checkpoint inhibitors
|British Journal of Cancer|2016|103